Obesity is a chronic medical condition characterised by excessive body fat accumulation that presents a significant risk to health. It's measured using the Body Mass Index (BMI), where a BMI of 30 or higher generally indicates obesity. In Australia, obesity rates have been steadily increasing, affecting both adults and children across all demographic groups.
The causes of obesity are multifactorial, including genetic predisposition, sedentary lifestyle, poor dietary habits, metabolic disorders, and psychological factors. Environmental influences such as easy access to high-calorie processed foods and reduced physical activity contribute substantially to weight gain. Some medical conditions, including thyroid disorders, polycystic ovary syndrome, and Cushing's syndrome, can also lead to obesity.
The health consequences of obesity are considerable. It increases the risk of developing type 2 diabetes, heart disease, high blood pressure, stroke, certain cancers, and sleep apnoea. Joint problems, fatty liver disease, and reduced mobility are also common complications. Additionally, obesity can impact mental health, leading to depression and reduced quality of life.
The Australian pharmaceutical market offers several medications to assist with weight management when combined with lifestyle modifications. These prescription medicines work through different mechanisms to help reduce appetite, increase metabolism, or inhibit fat absorption.
Orlistat is one of the most commonly used weight management medications available in Australia. It works by inhibiting pancreatic and gastric lipases, reducing fat absorption in the digestive system by approximately 30%. This medication is available both on prescription and over-the-counter in lower doses. Typical dosing is 120mg three times daily with meals. Common side effects include oily spotting, increased bowel movements, and urgent defecation, particularly after consuming high-fat foods.
Phentermine is an appetite suppressant belonging to the sympathomimetic amine class. It stimulates the central nervous system to reduce hunger and is typically prescribed for short-term use, usually 12 weeks or less. The standard dose is 15–30mg daily, taken in the morning. It's not recommended for individuals with cardiovascular disease, uncontrolled high blood pressure, or those taking certain psychiatric medications.
Topiramate, whilst primarily an anticonvulsant, has been shown to assist with weight loss and is sometimes prescribed off-label for obesity management in Australia. It works by affecting appetite regulation and increasing satiety. The typical dose ranges from 96–192mg daily in divided doses.
Naltrexone–bupropion combinations are newer options available in some Australian pharmacies. Naltrexone, an opioid antagonist, combined with bupropion, an antidepressant, work synergistically to promote weight loss through appetite suppression and increased energy expenditure. This combination requires careful monitoring and is not suitable for everyone.
GLP-1 receptor agonists such as semaglutide have recently become available for weight management in Australia. Originally developed for diabetes management, these medications have demonstrated significant weight loss benefits. They work by regulating appetite hormones and increasing feelings of fullness. These are typically administered as weekly injections and represent a newer class of anti-obesity medications.
Effective obesity management requires comprehensive lifestyle changes alongside any pharmaceutical interventions. Diet plays a crucial role in achieving sustainable weight loss. Various dietary approaches have proven effective for Australian patients, including Mediterranean-style diets rich in vegetables, whole grains, legumes, and healthy fats from olive oil and fish.
Low-carbohydrate diets have gained popularity and can be effective for short-term weight loss, though long-term adherence varies. Intermittent fasting, where eating is restricted to specific time windows, is another approach some individuals find sustainable. The key is finding an eating pattern that reduces overall calorie intake whilst providing adequate nutrition.
Regular physical activity is essential for weight management and overall health. The Australian guidelines recommend at least 150 minutes of moderate-intensity aerobic activity or 75 minutes of vigorous-intensity activity weekly, combined with muscle-strengthening activities at least twice per week. A combination of cardiovascular exercise and resistance training provides optimal results.
Behavioural modifications are equally important as dietary and exercise changes. Important strategies include:
Many patients benefit from working with dietitians, psychologists, or obesity specialists who provide structured support and accountability. Sleep quality and stress management significantly impact weight management success. Poor sleep increases hunger hormones and reduces satiety signals, making weight loss more difficult. Adequate sleep, typically 7–9 hours nightly, supports metabolic health and weight management efforts.
Managing obesity effectively often requires guidance from healthcare professionals. Your GP is an excellent starting point for discussing weight management strategies, assessing underlying health conditions, and determining whether medication is appropriate for your situation.
Dietitians are qualified professionals who provide personalised nutrition advice based on individual health status, preferences, and lifestyle. They help develop realistic eating plans, address nutritional deficiencies, and provide ongoing support and motivation. Exercise physiologists specialise in developing safe, effective exercise programmes tailored to individual fitness levels and health conditions. They're particularly valuable for those with joint problems or cardiovascular concerns.
Obesity medicine specialists are doctors with specialised training in weight management. They can conduct comprehensive assessments, manage complex medical cases, and make informed decisions about pharmacological interventions. Psychologists and counsellors address the emotional and behavioural aspects of obesity. They help identify triggers, develop coping strategies, and address underlying mental health conditions such as depression or eating disorders that may contribute to weight gain.
Regular medical monitoring is important when taking weight management medications. Healthcare providers assess medication effectiveness, monitor for side effects, check blood pressure and other vital signs, and adjust treatment as needed.
Weight loss success requires a long-term perspective. Rapid weight loss often results in weight regain, making sustainable, gradual weight loss preferable. A realistic goal of 0.5–1kg per week is generally considered healthy and maintainable. For individuals with obesity and related conditions such as type 2 diabetes or cardiovascular disease, weight management becomes part of comprehensive disease management. Even a 5–10% reduction in body weight can significantly improve blood sugar control, blood pressure, and overall health outcomes.
Certain populations require special considerations in obesity management. Pregnant women should not use weight loss medications and should focus on healthy eating and appropriate weight gain during pregnancy. Older adults may require modified approaches considering multiple medications and potential complications. Adolescents require age-appropriate interventions with family involvement.
Medical conditions that complicate obesity management include thyroid disorders, which require treatment before effective weight loss can occur, and hormonal imbalances that may benefit from specific interventions. Polycystic ovary syndrome, common in women with obesity, requires tailored management approaches. Maintaining weight loss after achieving goals requires ongoing commitment. Many people benefit from continuing healthy eating habits, regular physical activity, and periodic professional support. Some individuals maintain weight loss more successfully when continuing weight management medications long-term.
Australia offers various resources and support systems for individuals managing obesity. Many Australian pharmacies provide weight management services, including initial consultations and ongoing support for customers using weight loss medications.
Medicare covers consultations with GPs and can provide rebates for dietitian consultations when referred by a doctor. Many health insurance providers offer additional rebates for services such as exercise physiology and psychology support. Online resources, including government health websites and evidence-based community programmes, provide valuable information and support. Support groups, both online and in-person, connect individuals managing obesity and provide motivation and shared experience.
Public hospitals throughout Australia offer obesity management clinics in many regions, providing access to multidisciplinary teams including doctors, dietitians, and allied health professionals. These services may be particularly helpful for complex cases or those with limited private healthcare access.
Workplace wellness programmes increasingly incorporate weight management support, including gym memberships, health coaching, and nutrition education. These programmes recognise that supporting employee health contributes to overall wellbeing and productivity. Taking the first step toward weight management by consulting with a healthcare provider is the most important action. With comprehensive support, appropriate medications when indicated, lifestyle modifications, and professional guidance, sustainable weight loss and improved health outcomes are achievable for most individuals.
